IL17A and metabolic dysfunction-associated steatotic liver disease: Additionally, the KEGG analysis yielded 181 entries, 16 of which were directly related to the NAFLD, and three pathways that significantly enriched, including pathways in cancer, Th17 cell differentiation, and IL-17 signaling pathway, were retrieved as core pathways for FLD to treat NAFLD.